VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) — Richmond, Virginia

VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) is a clinical research site located in Richmond, Virginia, United States 23298.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) has participated in 1 clinical trials.

Therapeutic areas: Cervical Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh)?

VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) conducted?

VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) has 1 clinical trials on record. Their work covers Cervical Cancer.

Is VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) accredited by Crixeo Health?

VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about VCU Health, Investigational Drug Service (ATTN: Henly Deutsch, RPh)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.